WO2020096004A1 - 動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置 - Google Patents
動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置 Download PDFInfo
- Publication number
- WO2020096004A1 WO2020096004A1 PCT/JP2019/043713 JP2019043713W WO2020096004A1 WO 2020096004 A1 WO2020096004 A1 WO 2020096004A1 JP 2019043713 W JP2019043713 W JP 2019043713W WO 2020096004 A1 WO2020096004 A1 WO 2020096004A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- culture
- medium
- cells
- cell culture
- cell
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/58—Reaction vessels connected in series or in parallel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/18—External loop; Means for reintroduction of fermented biomass or liquid percolate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/26—Conditioning fluids entering or exiting the reaction vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M39/00—Means for cleaning the apparatus or avoiding unwanted deposits of microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/44—Means for regulation, monitoring, measurement or control, e.g. flow regulation of volume or liquid level
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/46—Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
- C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
Definitions
- the present invention relates to an animal cell growth promoter, an animal cell culture medium, and an animal cell culture device.
- a serum medium in which fetal bovine serum or the like is added to the medium as a factor having a function of maintaining cell growth or a serum-free medium in which hormones or growth factors are added in place of serum is generally used. ..
- Japanese Patent Laid-Open No. 2013-247927 discloses that rice bran extract has a growth promoting action on cultured animal cells.
- Japanese Patent Laid-Open No. 2011-182736 discloses that the cell growth rate can be increased by culturing animal cells in a medium containing a hydrolyzate of a ⁇ -conglycinin concentrate.
- JP-A-7-188292 discloses that a glycoprotein contained in the culture supernatant of human-derived fibroblasts promotes the growth of human vascular endothelial cells and hepatocytes.
- JP-A-5-301893 discloses that a protein contained in a cell culture supernatant obtained by culturing a human-derived glioma cell line has a growth promoting effect on glial cells and fibroblasts.
- the object of the present invention is to provide a novel animal cell growth promoter, animal cell culture medium and animal cell culture device.
- One embodiment according to the present invention is an animal cell growth promoter containing, as an active ingredient, the culture supernatant of the embryonic membrane of an avian or reptile egg.
- the egg may be a chicken egg.
- the animal cell growth promoter may be a cell growth agent for muscle cells, visceral cells, or nervous cells, or a cell growth agent for liver cells, pancreatic cells, or oviduct cells.
- Another embodiment of the present invention is a cell culture medium containing the cell growth promoter described in any of the above.
- Another embodiment according to the present invention is a first culture tank for culturing cells derived from embryonic membrane of an avian or reptile egg, a second culture tank for culturing animal cells for the purpose of proliferation, and A first flow path for flowing the medium from the first culture tank to the second culture tank; a second flow path for flowing the medium from the second culture tank to the first culture tank; The cell culture medium is refluxed in the order of the first flow channel, the second culture tank, and the second flow channel, and the first flow channel and the second flow channel are set according to the state of the animal cells and / or the cell culture medium.
- An animal cell culture device comprising: a medium flow rate control unit that controls the flow of the cell culture medium in a flow path.
- a medium introduction path for introducing a fresh cell culture medium into the refluxing cell culture medium, and a medium removal for removing the cell culture medium after culturing from the refluxing cell culture medium The medium flow rate control unit further comprises a passage, and the medium flow control unit introduces the fresh cell culture medium from the medium introduction passage and the medium removal passage according to the state of the animal cell and / or the cell culture medium. The removal of the culture medium for cell culture after the culture may be controlled.
- FIG. 1 It is a schematic diagram of the cell proliferation apparatus in one embodiment of the present invention.
- the tissue shown in the figure stomach, skeletal muscle, heart, gallbladder, intestine, brain, bursa of Fabricius and bone
- 5 is a photograph of observation results showing that cell proliferation is promoted in cells of No. 1 is a graph quantitatively showing the results of FIG. 1 for liver, pancreas, and oviduct-derived cells in one example of the present invention.
- cells derived from the tissues shown in the figure are a graph showing that cell proliferation is promoted by.
- Birds or reptiles that are the origin of the eggs that collect the germinal membranes include, but are not limited to, quail, chickens, lizards, snakes, crocodiles, turtles, etc., and are birds or reptile animals that have germinal membranes of eggs. I wish I had it.
- the embryonic membrane refers to a membrane tissue that is formed outside the embryo body during the development process of birds and reptiles, and has functions such as protection of the embryo, nutrition and respiration, and is not involved in the construction of the body after hatching or birth.
- the serosa located on the outermost side of the embryo, the amniotic membrane that wraps the embryo body, the allantois that creates the urinary sac, the chorioallantoic membrane (CAM) in which the serosa and allantois are partially adhered, and the yolk.
- CAM chorioallantoic membrane
- Examples include the yolk sac that wraps.
- the culture supernatant of the germinal membrane is a medium in which the germinal membrane is isolated and cultured.
- the germinal membrane to be cultured may be one kind or a mixture of plural kinds among the above-mentioned membranes such as serosa, amniotic membrane, allantoic membrane, allantoic membrane and yolk sac.
- the embryonic membrane can be collected from the egg by a known method (for example, see Eiji Ichishima: Chemistry and Biology, 13: 8, p489-497 (1975)).
- the embryo membrane can be isolated by the following method. First, after fertilized eggs are incubated for a predetermined period under conditions suitable for artificial hatching, the eggshell is split, and (1) the allantoic membrane is obtained by taking out the swollen membrane generated from the ventral side of the posterior part of the digestive tract of the embryo. (2) The amniotic membrane can be obtained by taking out the transparent membranous tissue around the fetus in which blood vessels are not running, and (3) the yolk sac is the membranous tissue surrounding the yolk.
- the serosa can be obtained by removing the outermost membranous tissue surrounding all the elements in the egg. Further, when the incubation time is extended, the serosa and the allanto partially fuse to form the chorioallantoic membrane. At this time, the chorioallantoic membrane is in contact with the eggshell and can be obtained by taking out the membrane tissue in which blood vessels are running.
- the optimal incubation period may be determined depending on each animal and the target membrane tissue. For example, in the case of chicken eggs, 4 days to 21 days are preferable, 10 days to 18 days are more preferable, and 13 days to 15 days is more preferred.
- these embryonic membranes When culturing these embryonic membranes, they may be cultured in a membranous state, but by physically disrupting the membrane or performing enzymatic treatment with a protease (eg, collagenase, elastase, dispase, papain). Alternatively, cells derived from the embryonic membrane may be isolated and cultured.
- a protease eg, collagenase, elastase, dispase, papain.
- cells derived from the embryonic membrane may be isolated and cultured.
- a medium used for general animal cell culture can be used, and examples thereof include, but are not limited to, DMEM and F12.
- supplements usually added as a medium additive may be added.
- the conditions used for usual animal cell culture can be used, and typically, a carbonate buffer medium is used for culturing at 5% CO 2, 37 ° C. It is not limited and can be appropriately selected by those skilled in the art.
- the culture time is not particularly limited, but is preferably 1 to 7 days, more preferably 2 to 6 days. After culturing, the supernatant may be collected and added to the cell culture medium as it is, but a medium obtained by removing solid matters such as cell debris by filtration or centrifugation may be added.
- the amount of the culture supernatant added to the cell culture medium is not particularly limited as long as it is an effective amount at which the growth effect of the cultured cells is recognized, but the final concentration in the medium is preferably 20% or more, more preferably 35% or more. , 50% or more is more preferable.
- the type of animal cells to be cultured in the cell culture medium to which this culture supernatant is added is not particularly limited, and muscle cells such as smooth muscle cells, cardiomyocytes and skeletal muscle cells, heart cells, hepatocytes, cells derived from the stomach Examples thereof include visceral cells such as cells derived from intestines, and neural cells such as nerve cells and glial cells.
- muscle cells such as smooth muscle cells, cardiomyocytes and skeletal muscle cells, heart cells, hepatocytes, cells derived from the stomach
- visceral cells such as cells derived from intestines
- neural cells such as nerve cells and glial cells.
- the animal species from which the cells are derived is not particularly limited, and examples thereof include humans, mice, rats, monkeys and pigs.
- this culture supernatant obtained by culturing cells derived from embryonic membrane to the animal cell culture medium, it is possible to promote the growth of the cultivated animal cells. Therefore, this culture supernatant can be used as an animal cell growth promoter.
- the cell expansion device of the present invention comprises a first culture tank for culturing cells derived from embryonic membrane of an avian or reptile egg, a second culture tank for culturing animal cells for the purpose of proliferation, and a first culture.
- the cell culture medium is refluxed in the order of the channel, the second culture tank, and the second channel, and the first channel and the second channel are flown according to the state of the animal cells and / or the cell culture medium.
- a medium flow rate control unit that controls the flow of the cell culture medium.
- the first culture tank culture according to the method for culturing cells derived from embryonic membrane, which is performed when preparing the animal cell growth promoting agent as described above, is performed.
- the second culture tank culturing according to the culturing method of culturing animal cells in the medium to which the animal cell growth promoter is added as described above is performed.
- the first culture tank and the second culture tank are fluidly connected by the first flow path and the second flow path.
- the first culture tank 11 and the second culture tank 12 may be directly connected by the first flow channel 21 and the second flow channel 22.
- one or a plurality of other culture tanks may be provided, and the other culture tank and the first culture tank 11 or Various configurations can be considered for connection with the two culture tanks 12.
- a third culture tank 13 is provided in the middle of the first flow path 21, and the flow path extends from the first culture tank 11 through the third culture tank 13 to the second culture tank 13. It may be connected to the tank 12.
- FIG. 1 (B) a third culture tank 13 is provided in the middle of the first flow path 21, and the flow path extends from the first culture tank 11 through the third culture tank 13 to the second culture tank 13. It may be connected to the tank 12.
- FIG. 1 (B) a third culture tank 13 is provided in the middle of the first flow path 21, and the flow path extends from the first culture tank 11 through the third culture tank 13 to the second culture tank 13.
- a third culture tank 13 is provided independently of the second culture tank 12, and the flow channels are the first flow channel 21 and the second flow channel 22. Separately, a third channel 31 and a fourth channel 32 that fluidly connect the first culture tank 11 and the third culture tank 13 may be provided.
- the cells are cultured in the first culture tank 11 or the second culture tank 12. Can affect or influence their culture.
- the influence of the culture in the first culture tank 11 and the culture in the culture tanks other than the second culture tank 12 from the culture in the first culture tank and the culture in the second culture tank There are various possible effects on the culture in the first culture tank and the culture in the second culture tank.
- cell growth, cell differentiation, tissue morphogenesis, pH adjustment of the medium Examples include prevention of bacterial contamination.
- the third culture tank 13 cells that are different from the cells in the second culture tank 12 and that can grow in a medium in which cells derived from germinal membrane are cultivated.
- the cells can be simultaneously grown in the second culture tank 12 and the third culture tank 13.
- by culturing cells derived from the embryonic membrane different from the first culturing tank 11 in the third culturing tank 13 it is possible to further promote the growth of the cells cultivated in the second culturing tank 12. it can.
- the cells cultured in the third culture tank 13 are cells capable of growing in a medium in which cells derived from germinal membranes are cultured and secreting factors that grow the cells cultured in the second culture tank 12. Good.
- the tanks may be connected to each other by a pipe, and the pipe may form a flow path.
- a valve may be installed in these pipes.
- the medium flow rate control unit monitors the state of the cells being cultured and / or the medium for cell culture, and according to the state, the flow of the medium for cell culture in each flow path through this valve (for example, flow velocity, flow rate, etc.). ) May be controlled.
- the structure of the valve is not particularly limited as long as it is a well-known structure such as a flange type or a screw type, and the method for adjusting the valve is not particularly limited, and a known structure such as an air-driven type, an electromagnetic type, an electric type, or a hydraulic type is used. Any adjustment method may be used. Further, in order to prevent the backflow of the cell culture medium in the tube, the tube may be provided with a check valve.
- Examples of the state of the cells and / or cell culture medium monitored by the medium flow rate control unit include, but are not limited to, the state of cell proliferation, the state of cell differentiation, and the pH of the medium.
- the state of cell proliferation can be determined by, for example, counting the number of cells per unit area or measuring the ratio of the area occupied by cells to the bottom area of the plate.
- the state of cell differentiation can be determined by measuring fluorescence by, for example, introducing into the cells a marker gene that expresses upon differentiation and emits fluorescence.
- the pH of the medium for example, the pH may be directly measured, or a pigment that changes depending on the pH may be added to the medium and the color may be used for the determination.
- a fertilized egg of a chicken is incubated at 37 ° C, and 14 days later, the eggshell is broken, and the membrane tissue in contact with the eggshell and in which blood vessels are running is taken out as chorioallantoic membrane, while the membrane surrounding the yolk is taken out.
- the tissue was taken out as an yolk sac and each of these membrane tissues was immersed in HBSS (Hank's Balanced Salt Solution). These membrane tissues were physically finely cut with tweezers or the like, and then centrifuged to remove the supernatant.
- a collagenase solution (200 IU / mL) was added to each isolated membrane tissue, and the mixture was kept at 37 ° C for 1 hour and then centrifuged again to remove the supernatant.
- HBSS was added to each collagenase-treated membrane tissue, filtered through a 40 ⁇ m filter, and the resulting filtrate was centrifuged to remove the supernatant to collect chorioallantoic membrane-derived cells or yolk sac-derived cells.
- the chorioallantoic membrane-derived cells or yolk sac-derived cells are preserved, the cells are suspended in a cell freezing solution (10% DMSO solution) and frozen by gradually cooling to -80 ° C, and then -80 ° C. Saved in.
- the chorioallantoic membrane-derived cell or yolk sac-derived cell obtained in (1) contains 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (PS) solution
- FBS fetal bovine serum
- PS penicillin-streptomycin
- the cells were seeded in a cell culture dish (diameter 10 cm) at a concentration of 4 ⁇ 10 6 cells / dish, and the amount was 2 to 3 at 37 ° C. and 5% CO 2 environment. Cultured for 4 days.
- fertilized chicken eggs were incubated at 37 ° C, and 14 days later, the eggshells were broken and the chicken embryos were taken out.
- a stomach, skeletal muscle, heart, gall bladder, intestine, brain, bursa of Fabricius and bone were isolated from the embryonic day 14 chicken, and each was immersed in an HBSS solution. Then, cells derived from each tissue were isolated by the same method as in (1).
- the culture solution of cells derived from each tissue was removed from the dish, and PBS was added to wash the cells. After removing the PBS, a trypsin-EDTA solution was added and the cells were detached by incubating at 37 ° C. for 1 to 2 minutes, and then FBS / PS-containing DMEM was added to stop the reaction. All the solution containing the detached cells was collected and centrifuged to obtain cells. Further, FBS.PS was added to the cells to suspend the cells, and 20 ⁇ L of the cell suspension was mixed with 20 ⁇ L of trypan blue solution. The number of live cells not stained with trypan blue in this cell suspension was counted under a microscope using a hemocytometer.
- FIG. 3 shows the average number of cells and the standard error in the case of using the chorioallantoic membrane culture supernatant for cells derived from the liver, pancreas, and oviduct in three petri dishes.
- the addition of chorioallantoic membrane culture supernatant resulted in approximately 2.5 to 4 times more cells than the case without addition of chorioallantoic membrane culture supernatant.
- the addition of chorioallantoic membrane culture supernatant resulted in approximately 2.5 to 4 times more cells than the case without addition of chorioallantoic membrane culture supernatant. was growing.
- the present invention has made it possible to provide a novel animal cell growth promoter, an animal cell culture medium, and an animal cell culture device.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
本出願は、2018年11月8日付で出願した日本国特許出願2018-210910に基づく優先権を主張するものであり、当該基礎出願を引用することにより、本明細書に含めるものとする。
本開示の動物細胞増殖促進剤は、鳥類または爬虫類の卵の胚膜の培養上清を有効成分として含有する。
本発明の細胞増殖装置は、鳥類または爬虫類の卵の胚膜由来の細胞を培養する第1の培養槽と、増殖を目的とする動物細胞を培養する第2の培養槽と、第1の培養槽から第2の培養槽へ培地を流す第1の流路と、第2の培養槽から第1の培養槽へ培地を流す第2の流路と、第1の培養槽、第1の流路、第2の培養槽、第2の流路の順に細胞培養用培地を還流させ、前記動物細胞及び/又は前記細胞培養用培地の状態に従って、第1の流路及び第2の流路における前記細胞培養用培地の流れを制御する培地流量制御部と、を備える。
試験に用いる漿尿膜又は卵黄嚢は、以下の方法によってそれぞれ単離した。
(1)で得られた漿尿膜由来細胞又は卵黄嚢由来細胞を10%ウシ胎児血清(FBS)および1%ペニシリン・ストレプトマイシン(PS)溶液を含有したDMEM(以下、FBS・PS含有DMEMと称する)に加え、4×106cells/dishの濃度で細胞培養用ディッシュ(直径10cm)に播種し、37℃、5%CO2環境下で2~4日間培養した。
(2)で示した培養方法によって調製した漿尿膜培養液又は卵黄嚢培養液を0.22μmのフィルターを用いてろ過し、得られた濾液を動物細胞増殖促進剤として動物細胞培養に用いた。なお、調製した培養上清を保存する場合には、-20℃で凍結して保存した。
(4-1)各組織からの細胞の単離方法
培養に用いるニワトリ細胞は、以下の方法によって単離した。
各組織由来の細胞は、FBS・PS含有DMEMに(3)で調製した漿尿膜培養上清又は卵黄嚢培養上清を等量加えた培養用培地を用いて、(2)と同様の方法で培養を行った。なお、対照として、漿尿膜培養上清又は卵黄嚢培養上清を添加せずにFBS・PS含有DMEMのみの培地を用いた以外は同じ条件で培養した細胞を用いた。
(4-2)の結果を、肝臓、膵臓、輸卵管、胃、筋肉、心臓、腸、脳、ファブリキウス嚢及び骨由来の細胞について、定量的に評価した。ここで、各組織由来の細胞数は、以下の方法によって計測した。
まず、漿尿膜培養上清を添加した培地で約3~5日間培養した時の細胞を位相差顕微鏡で観察した。図2にその細胞の写真を示すが、どの細胞を培養した場合も、(3)で調製した漿尿膜培養上清を添加した場合のほうが、漿尿膜培養上清を添加しない場合より細胞数が多かった。これは、添加した漿尿膜培養上清によって細胞の増殖が促進されたことを示している。
Claims (8)
- 鳥または爬虫類の有精卵由来の胚膜の培養上清を有効成分として含有する動物細胞培養増殖促進剤
- 前記胚膜が羊膜、漿尿膜及び卵黄嚢からなる群から選択される少なくとも1種である、請求項1に記載の動物細胞増殖促進剤。
- 前記卵が鶏卵である、請求項1又は2に記載の動物細胞増殖促進剤。
- 筋肉系細胞、内臓系細胞、または神経系細胞に対する細胞増殖剤である、請求項1~3のいずれか1項に記載の動物細胞増殖促進剤。
- 肝臓細胞、膵臓細胞、輸卵管細胞に対する細胞増殖剤である、請求項1~3のいずれか1項に記載の動物細胞増殖促進剤。
- 請求項1~5のいずれか1項に記載の細胞増殖促進剤を含有する細胞培養用培地。
- 鳥類または爬虫類の卵の胚膜由来の細胞を培養する第1の培養槽と、
増殖を目的とする動物細胞を培養する第2の培養槽と、
第1の培養槽から第2の培養槽へ培地を流す第1の流路と、
第2の培養槽から第1の培養槽へ培地を流す第2の流路と、
第1の培養槽、第1の流路、第2の培養槽、第2の流路の順に細胞培養用培地を還流させ、前記動物細胞及び/又は前記細胞培養用培地の状態に従って、第1の流路及び第2の流路における前記細胞培養用培地の流れを制御する培地流量制御部と、を備える動物細胞培養装置。 - 前記還流する前記細胞培養用培地に新鮮な細胞培養用培地を導入するための培地導入路と、
前記還流する前記細胞培養用培地から培養後の細胞培養用培地を除去するための培地除去路と、をさらに有し、
前記培地流量制御部は、前記動物細胞及び/又は前記細胞培養用培地の状態に従って、前記培地導入路からの前記新鮮な細胞培養用培地の導入及び前記培地除去路からの前記培養後の細胞培養用培地の除去を制御する、請求項7に記載の動物細胞培養装置。
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19883197.6A EP3878941A4 (en) | 2019-11-07 | Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus | |
CN201980074375.3A CN113015789A (zh) | 2018-11-08 | 2019-11-07 | 动物细胞增殖促进剂、动物细胞培养用培养基和动物细胞培养装置 |
JP2020555593A JP7488571B2 (ja) | 2018-11-08 | 2019-11-07 | 動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置 |
SG11202104775SA SG11202104775SA (en) | 2018-11-08 | 2019-11-07 | Animal Cell Growth Promoter, Medium For Culturing Animal Cells, And Device For Culturing Animal Cells |
US17/292,131 US20210395678A1 (en) | 2018-11-08 | 2019-11-07 | Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus |
KR1020217016436A KR20210091195A (ko) | 2018-11-08 | 2019-11-07 | 동물 세포 증식 촉진제, 동물 세포 배양용 배지 및 동물 세포 배양 장치 |
JP2023207262A JP2024028914A (ja) | 2018-11-08 | 2023-12-07 | 動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018210910 | 2018-11-08 | ||
JP2018-210910 | 2018-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020096004A1 true WO2020096004A1 (ja) | 2020-05-14 |
Family
ID=70612097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2019/043713 WO2020096004A1 (ja) | 2018-11-08 | 2019-11-07 | 動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210395678A1 (ja) |
JP (2) | JP7488571B2 (ja) |
KR (1) | KR20210091195A (ja) |
CN (1) | CN113015789A (ja) |
SG (1) | SG11202104775SA (ja) |
WO (1) | WO2020096004A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023132371A1 (ja) * | 2022-01-07 | 2023-07-13 | インテグリカルチャー株式会社 | 肝臓由来の細胞の培養方法および肝臓由来の細胞を含む培養系 |
JP7323966B1 (ja) * | 2023-03-10 | 2023-08-09 | ダイバースファーム株式会社 | 培養用組成物を製造する方法 |
WO2023149408A1 (ja) * | 2022-02-02 | 2023-08-10 | 株式会社ユーグレナ | 化粧料組成物、表皮角化細胞増殖用化粧料組成物、表皮角化細胞増殖剤、抗酸化剤、毛乳頭細胞増殖用化粧料組成物、毛乳頭細胞増殖剤、育毛剤、ロリクリン遺伝子発現促進剤、ヘムオキシゲナーゼ-1遺伝子発現促進剤及びコーニファイドエンベロープ形成促進剤 |
WO2023229039A1 (ja) * | 2022-05-27 | 2023-11-30 | 学校法人東京女子医科大学 | 細胞培養方法 |
WO2024024857A1 (ja) * | 2022-07-27 | 2024-02-01 | インテグリカルチャー株式会社 | 細胞状態推定システム |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61209585A (ja) * | 1985-03-14 | 1986-09-17 | Q P Corp | 細胞用培地 |
JPS62166883A (ja) * | 1986-01-20 | 1987-07-23 | Q P Corp | 動物細胞用培地 |
JPH05301893A (ja) | 1991-02-14 | 1993-11-16 | Takeda Chem Ind Ltd | グリア活性化因子およびその製造法 |
JPH07188292A (ja) | 1994-08-19 | 1995-07-25 | Snow Brand Milk Prod Co Ltd | ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤 |
JP2006280234A (ja) * | 2005-03-31 | 2006-10-19 | Hitachi Medical Corp | 細胞の増殖又は分化方法 |
JP2011182736A (ja) | 2010-03-10 | 2011-09-22 | Fuji Oil Co Ltd | 動物細胞培養用培地 |
JP2013247927A (ja) | 2012-06-01 | 2013-12-12 | Univ Of Fukui | 米糠由来の細胞増殖促進剤 |
WO2017191691A1 (ja) * | 2016-05-02 | 2017-11-09 | インテグリカルチャー株式会社 | 成長誘導システム、成長誘導制御装置、成長誘導制御方法、および、成長誘導制御プログラム |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993002182A1 (en) * | 1991-07-15 | 1993-02-04 | Edison Animal Biotechnology Center, Ohio University | Yolk sac stem cells |
KR100834731B1 (ko) * | 2003-01-07 | 2008-06-13 | 주식회사 바이오랜드 | 세포 배양에 대한 기질 또는 기저막으로서 양막의 이용과이를 이용한 세포 치료제로서의 제조 방법 및 이의 용도 |
US20070178586A1 (en) | 2005-11-09 | 2007-08-02 | The Ohio State University Research Foundation | Methods and apparatuses for growing cells |
US8367409B2 (en) * | 2008-11-19 | 2013-02-05 | Anthrogenesis Corporation | Amnion derived adherent cells |
CN101497874B (zh) * | 2009-03-04 | 2012-05-23 | 中山大学中山眼科中心 | 一种促进体细胞增殖的方法 |
CN201626960U (zh) * | 2010-02-01 | 2010-11-10 | 中国农业科学院北京畜牧兽医研究所 | 用于干细胞培养的灌流装置 |
CN102329771A (zh) * | 2011-10-12 | 2012-01-25 | 佛山科学技术学院 | 长期传代培养鸡胚胎干细胞的方法及其专用培养基 |
US20140255447A1 (en) * | 2013-03-05 | 2014-09-11 | Biomune Company | Production of avian embryo cells |
CN104099294A (zh) * | 2013-04-03 | 2014-10-15 | 北京京蒙高科干细胞技术有限公司 | 基于干细胞分泌因子的培养基及其制备和使用方法 |
CN103289952A (zh) * | 2013-06-04 | 2013-09-11 | 厦门大学 | 一种细胞或组织的培养方法 |
CN104818244B (zh) * | 2015-05-21 | 2017-12-29 | 天晴干细胞股份有限公司 | 一种羊膜上皮细胞分离、培养的方法 |
CN105316309A (zh) * | 2015-12-04 | 2016-02-10 | 广州赛莱拉干细胞科技股份有限公司 | 一种消化酶组合物及成纤维细胞和饲养层细胞的制备方法 |
US11292999B2 (en) | 2016-08-30 | 2022-04-05 | Finesse Solutions, Inc. | Bioreactor with multiple coupled vessels |
CN107058217A (zh) * | 2017-01-22 | 2017-08-18 | 广州赛莱拉干细胞科技股份有限公司 | 一种软骨细胞的增殖培养基及增殖培养方法 |
KR102121042B1 (ko) * | 2017-12-06 | 2020-06-09 | 이정복 | 조류의 에그로부터 분리한 세포인 배반엽 전분화능세포, 신경줄기세포, 배아섬유아세포 컨디션드 배지를 유효성분으로 하는 세포 증식, 피부재생 및 주름 개선용 배지 조성물 |
CN108373995B (zh) * | 2018-02-14 | 2020-11-17 | 浙江生创精准医疗科技有限公司 | 一种干细胞条件培养基、其制备方法和用途 |
-
2019
- 2019-11-07 US US17/292,131 patent/US20210395678A1/en active Pending
- 2019-11-07 SG SG11202104775SA patent/SG11202104775SA/en unknown
- 2019-11-07 WO PCT/JP2019/043713 patent/WO2020096004A1/ja unknown
- 2019-11-07 KR KR1020217016436A patent/KR20210091195A/ko active IP Right Grant
- 2019-11-07 JP JP2020555593A patent/JP7488571B2/ja active Active
- 2019-11-07 CN CN201980074375.3A patent/CN113015789A/zh active Pending
-
2023
- 2023-12-07 JP JP2023207262A patent/JP2024028914A/ja active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61209585A (ja) * | 1985-03-14 | 1986-09-17 | Q P Corp | 細胞用培地 |
JPS62166883A (ja) * | 1986-01-20 | 1987-07-23 | Q P Corp | 動物細胞用培地 |
JPH05301893A (ja) | 1991-02-14 | 1993-11-16 | Takeda Chem Ind Ltd | グリア活性化因子およびその製造法 |
JPH07188292A (ja) | 1994-08-19 | 1995-07-25 | Snow Brand Milk Prod Co Ltd | ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤 |
JP2006280234A (ja) * | 2005-03-31 | 2006-10-19 | Hitachi Medical Corp | 細胞の増殖又は分化方法 |
JP2011182736A (ja) | 2010-03-10 | 2011-09-22 | Fuji Oil Co Ltd | 動物細胞培養用培地 |
JP2013247927A (ja) | 2012-06-01 | 2013-12-12 | Univ Of Fukui | 米糠由来の細胞増殖促進剤 |
WO2017191691A1 (ja) * | 2016-05-02 | 2017-11-09 | インテグリカルチャー株式会社 | 成長誘導システム、成長誘導制御装置、成長誘導制御方法、および、成長誘導制御プログラム |
Non-Patent Citations (1)
Title |
---|
EIJI ICHISHIMA, KAGAKU TO SEIBUTSU, vol. 13, no. 8, 1975, pages 489 - 497 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023132371A1 (ja) * | 2022-01-07 | 2023-07-13 | インテグリカルチャー株式会社 | 肝臓由来の細胞の培養方法および肝臓由来の細胞を含む培養系 |
WO2023149408A1 (ja) * | 2022-02-02 | 2023-08-10 | 株式会社ユーグレナ | 化粧料組成物、表皮角化細胞増殖用化粧料組成物、表皮角化細胞増殖剤、抗酸化剤、毛乳頭細胞増殖用化粧料組成物、毛乳頭細胞増殖剤、育毛剤、ロリクリン遺伝子発現促進剤、ヘムオキシゲナーゼ-1遺伝子発現促進剤及びコーニファイドエンベロープ形成促進剤 |
WO2023229039A1 (ja) * | 2022-05-27 | 2023-11-30 | 学校法人東京女子医科大学 | 細胞培養方法 |
WO2024024857A1 (ja) * | 2022-07-27 | 2024-02-01 | インテグリカルチャー株式会社 | 細胞状態推定システム |
JP7323966B1 (ja) * | 2023-03-10 | 2023-08-09 | ダイバースファーム株式会社 | 培養用組成物を製造する方法 |
Also Published As
Publication number | Publication date |
---|---|
US20210395678A1 (en) | 2021-12-23 |
CN113015789A (zh) | 2021-06-22 |
EP3878941A1 (en) | 2021-09-15 |
JPWO2020096004A1 (ja) | 2021-09-24 |
KR20210091195A (ko) | 2021-07-21 |
SG11202104775SA (en) | 2021-06-29 |
JP7488571B2 (ja) | 2024-05-22 |
JP2024028914A (ja) | 2024-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020096004A1 (ja) | 動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置 | |
Colnot et al. | Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development | |
AU2001234998B2 (en) | Isolation and transplantation of retinal stem cells | |
Moase et al. | Delayed neural crest cell emigration from Sp and Spd mouse neural tube explants | |
CN104350145B (zh) | 用于无饲养细胞培养牛和猪的精原干细胞的方法 | |
WO2019023693A1 (en) | ESTABLISHING A TOPOGRAPHIC ORGANIZATION IN A THREE DIMENSIONAL FABRIC CULTURE | |
JP2023504217A (ja) | 種特異的な又は属特異的なタンパク質で細胞の成長を増進する方法及びその用途 | |
RU2620947C2 (ru) | Биосинтетические системы проксимального канальца и способы использования | |
Edwards et al. | Genetic manipulation of mammary epithelium by transplantation | |
JP2007501625A (ja) | 鳥類精原幹細胞の培養方法及びこれにより収得した鳥類精原幹細胞 | |
Kumar et al. | Long-term primary culture of neurons taken from chick embryo brain: A model to study neural cell biology, synaptogenesis and its dynamic properties | |
JP4343946B2 (ja) | 鳥類の始原生殖細胞の生殖系列転移効率の改善方法 | |
WO2023132371A1 (ja) | 肝臓由来の細胞の培養方法および肝臓由来の細胞を含む培養系 | |
JP4267689B2 (ja) | 鳥類由来の細胞の培養方法および該培養方法によって得られた細胞系 | |
CN103571793B (zh) | 一种调控诱导产生的视网膜前体细胞的方法 | |
JP4376901B2 (ja) | 精原細胞を利用した鳥類キメラの生産方法及び鳥類キメラ | |
CN105073978B (zh) | 利用植物干细胞或植物去分化干细胞的提取物诱导定制亚全能干细胞的方法以及利用该方法的方式制得的亚全能干细胞 | |
JP2005507234A (ja) | 始原生殖細胞ベースの、鳥の生殖細胞系の作製 | |
Hanssen et al. | Reverse Engineering of Feedforward Cortical-Hippocampal Neural Networks Relevant for Preclinical Disease Modelling | |
WO2024147330A1 (ja) | 筋肉由来の細胞の培養方法および筋肉由来の細胞を含む培養装置 | |
CN113801943B (zh) | miR-450b-3p对脂肪细胞聚酯的调控作用及其应用 | |
Sritabtim et al. | First study on repeatable culture of primordial germ cells from various embryonic regions with giant feeder cells in Japanese quail (Coturnix japonica) | |
WO2014069431A1 (ja) | 増大された継代能を有する神経幹細胞、前記増大された継代能を有する神経幹細胞の製造方法、神経幹細胞の継代能を増大させるための神経幹細胞の培養方法 | |
Wiatrak | Establishment and Characterization of Organoids from Mammary Tissue of Lactating Dairy Cows | |
JPWO2005040361A1 (ja) | 幹細胞の簡易調製法およびそれに使用するフィーダー細胞 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19883197 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2020555593 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20217016436 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2019883197 Country of ref document: EP Effective date: 20210608 |